1797 completed, 477 unknown, 277 recruiting, 192 terminated. 1382 Not applicable, 326 Phase 2, 324 Phase 4, 304 Phase 3, 129 Phase 1.
Follow Urological Manifestations: new trials by email Literature Review of Urological Manifestations trials Research Report on Urological Manifestations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| School-Based Bladder Health Intervention Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms | Not applicable | Withdrawn | Stanford University | 2028-01-01 | 2026-05-07 | |
| Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children Urgent PC - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | Chi Dang Hornik | 50 | 2027-04-01 | 2026-06-17 |
| Target Physiotherapy Versus Exercise Support Intervention for Bladder-bowel Dysfunction in Adolescents With Obesity Target physiotherapy, Exercise support intervention, Usual obesity care - Bladder-Bowel Dysfunction, Obesity & Overweight | Not applicable | Not yet recruiting | University of Lisbon | 237 | 2027-01-04 | 2026-07-23 |
| Peroneal Neuromodulation vs Pelvic Floor Exercises in OAB Transcutaneous Peroneal Electrical Neuromodulation, Pelvic Floor Exercise - Overactive Bladder (OAB), Neuromodulation | Not applicable | Not yet recruiting | Marmara University | 60 | 2026-12-01 | 2026-08-26 |
| A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy zigakibart, atrasentan, Placebo - IgA Nephropathy (IgAN) | Phase 3 | Not yet recruiting | Novartis Pharmaceuticals | 340 | 2026-12-01 | 2026-09-30 |
| Male Pelvic Floor Muscle Rehabilitation Exercises Male Pelvic Floor Rehabilitation #1 - Erectile Dysfunction, Urinary Incontinence | Not applicable | Not yet recruiting | Dream Video LLC | 100 | 2026-12-01 | 2026-10-07 |
| Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction InterStim™ Sacral Neuromodulation System II - X - Overactive Bladder (OAB), Urgency Urinary Incontinence | Not yet recruiting | Fundación Santa Fe de Bogota | 1700 | 2026-12-01 | 2026-10-02 | |
| Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response Artificial intelligence clinical decision support model - Urinary Incontinence (UI) | Not yet recruiting | Javier Pereira | 80 | 2026-12-01 | 2026-10-21 | |
| An Observational, Multinational, In Hospital Evaluation of Catheter Utilization Rates in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter Across Europe and the Middle East PureWick™ Flex Female External Catheter (FFEC), Indwelling Urinary Catheter (IUC) - Urinary Incontinence, Limited Mobility | Not yet recruiting | Becton, Dickinson and Company | 240 | 2026-11-06 | 2026-09-01 | |
| Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Phase 4 | Not yet recruiting | University of California, Los Angeles | 120 | 2026-11-01 | 2026-09-15 |
| Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder Mirabegron (beta3-adrenoceptor agonist) - Overactive Bladder (OAB) | Not yet recruiting | Bagcilar Training and Research Hospital | 115 | 2026-11-01 | 2026-10-05 | |
| Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria Electronic Health Record alert - Referral and Consultation, Glomerulonephritis | Not applicable | Not yet recruiting | Geisinger Clinic | 1200 | 2026-11-01 | 2026-05-12 |
| Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy Urotherapy Education - Duchenne Muscular Dystrophy (DMD), Lower Urinary Tract Symptoms (LUTS) | Not applicable | Not yet recruiting | Lokman Hekim University | 50 | 2026-11-01 | 2026-09-15 |
| Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems Patient reminder system - Pelvic Organ Prolapse, Urinary Incontinence | Not applicable | Recruiting | Ohio State University | 162 | 2026-11-01 | 2026-09-24 |
| Strategy for Managing Urinary Incontinence With PRP Plasma rich platelet injection, Blood test, cytobacteriological examination of urine - Urinary Incontinence, Platelet Rich Plasma | Not applicable | Not yet recruiting | GCS Ramsay Santé pour l'Enseignement et la Recherche | 41 | 2026-10-30 | 2026-09-22 |
| An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases ManNAc - Focal Segmental Glomerulosclerosis, Minimal Change Disease | Phase 2 | Recruiting | National Human Genome Research Institute (NHGRI) | 30 | 2026-10-27 | 2026-10-22 |
| Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease | Phase 4 | Not yet recruiting | VA Office of Research and Development | 146 | 2026-10-21 | 2026-10-19 |
| Diagnostic Work-up of Nephrocalcinosis in Children Nephrocalcinosis | Not yet recruiting | Assiut University | 40 | 2026-10-20 | 2026-10-20 | |
| HIFEM for Incontinence After Menopause High-Intensity Focused Electromagnetic (HIFEM) Pelvic floor training as described in point a above, with the addition of HIFEM., Pelvic Floor exercises - Urinary Incontinence (UI) | Not applicable | Not yet recruiting | Göteborg University | 100 | 2026-10-15 | 2026-09-15 |
| How Well and Safely Does Lemborexant Work for People Who Wake up at Night to Urinate (LENS) Lemborexant tablets, Placebo - Nocturia | Phase 4 | Not yet recruiting | University of Alberta | 35 | 2026-10-15 | 2026-09-25 |
Showing 20 of 3108. Sign in to see all of them.
Urinary Incontinence (934) · Urinary Bladder, Overactive (801) · Urinary Incontinence, Stress (641) · Lower Urinary Tract Symptoms (397) · Proteinuria (319) · Urinary Incontinence, Urge (241) · Prostatic Hyperplasia (186) · Albuminuria (138) · Nocturia (131) · Renal Insufficiency, Chronic (123) · Pelvic Organ Prolapse (99) · Hypertension (75) · Prostatic Neoplasms (75) · Diabetic Nephropathies (73) · Pelvic Floor Disorders (62)
Pathological Conditions, Signs and Symptoms (3108) · Signs and Symptoms (3104) · Urogenital Diseases (2894) · Male Urogenital Diseases (2882) · Female Urogenital Diseases and Pregnancy Complications (2744) · Female Urogenital Diseases (2739) · Urologic Diseases (2693) · Lower Urinary Tract Symptoms (2208) · Urination Disorders (2075) · Urinary Bladder Diseases (875) · Urinary Incontinence (658) · Genital Diseases (359) · Genital Diseases, Male (281) · Kidney Diseases (276)
Solifenacin Succinate (107) · mirabegron (87) · Botulinum Toxins, Type A (78) · Tolterodine Tartrate (69) · Tamsulosin (42) · fesoterodine (42) · Suburethral Slings (29) · oxybutynin (28) · Surveys and Questionnaires (23) · Exercise (22) · Losartan (22) · Transcutaneous Electric Nerve Stimulation (20) · Duloxetine Hydrochloride (19) · darifenacin (19) · Deamino Arginine Vasopressin (18)
Astellas Pharma Inc (50) · Pfizer (36) · Allergan (30) · National Taiwan University Hospital (30) · Cairo University (25) · University Hospital, Ghent (22) · Coloplast A/S (20) · Ferring Pharmaceuticals (20) · Riphah International University (20) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (19) · Far Eastern Memorial Hospital (18) · Seoul National University Hospital (18) · Eli Lilly and Company (17) · Samsung Medical Center (17) · University of California, San Francisco (17)
United States (1018) · Turkey (Türkiye) (267) · Canada (200) · France (188) · United Kingdom (158) · Spain (139) · Germany (135) · Italy (128) · China (123) · South Korea (122) · Taiwan (117) · Denmark (116) · Belgium (109) · Egypt (104) · Netherlands (97)
Kenneth Peters, MD (14) · Kyu-Sung Lee, Ph.D (12) · Ho-Hsiung Lin, PhD (11) · Seyda Toprak Celenay (10) · Hann-Chorng Kuo, M.D. (8) · Rose Khavari, MD (8)
PMID 39704322, PMID 37160401, PMID 37888839, PMID 37811598, PMID 19941278, PMID 38299639, PMID 12559262, PMID 37916745, PMID 38682786, PMID 32378735, PMID 33107592, PMID 34778952, PMID 37070660, PMID 40709601, PMID 17049716, PMID 28754926, PMID 30288727, PMID 35881009, PMID 38018702, PMID 19937315, PMID 36148895, PMID 41805697, PMID 11857671, PMID 12811491, PMID 21344495, PMID 24246044, PMID 25623739, PMID 26337427, PMID 26573101, PMID 29873008, PMID 32769645, PMID 32791124, PMID 34164803, PMID 9083302, PMID 15014933, PMID 15227649, PMID 15540753, PMID 16406907, PMID 16804634, PMID 16942457, PMID 16985862, PMID 17905093, PMID 18499184, PMID 19302497, PMID 20018326, PMID 20035977, PMID 20093904, PMID 21293089, PMID 21367921, PMID 21944127
2016 (7), 2017 (7), U10HD041261 (7), U10HD041267 (7), 2019 (6), U10HD041250 (6), 2009 (5), 2015 (5), 2023 (5), U01HD041249 (5), 2008 (4), 2014 (4), 2018 (4), U10HD041263 (4), U10HD054214 (4)